| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EJI.1830190620 |
| P698 | PubMed publication ID | 2666143 |
| P2093 | author name string | Saunders D | |
| Gerardy-Schahn R | |||
| Bitter-Suermann D | |||
| Ambrosius D | |||
| Casaretto M | |||
| Görgen S | |||
| Karwarth G | |||
| Mittler C | |||
| P2860 | cites work | Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity | Q29618557 |
| PLATELET SEQUESTRATION IN MAN. I. METHODS. | Q33355155 | ||
| Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
| Biochemistry and biology of anaphylatoxins | Q34183073 | ||
| Reduced surface expression and binding of fibronectin by thrombin-stimulated thrombasthenic platelets | Q35204377 | ||
| Rapid modulation of N-formyl chemotactic peptide receptors on the surface of human granulocytes: formation of high-affinity ligand-receptor complexes in transient association with cytoskeleton | Q36210501 | ||
| Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement | Q36268183 | ||
| Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum | Q36269678 | ||
| Immunoprecipitation and partial characterization of diphtheria toxin-binding glycoproteins from surface of guinea pig cells | Q37314295 | ||
| Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose | Q39341708 | ||
| Structure and function of the anaphylatoxins | Q40190947 | ||
| Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. | Q40475508 | ||
| Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion | Q42936090 | ||
| Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies. | Q52559536 | ||
| Synthetic C3a analogs as specific inhibitors of C3a activity. | Q53945056 | ||
| Interaction of fibronectin with its receptor on platelets | Q68939916 | ||
| Crystal structure analysis and molecular model of human C3a anaphylatoxin | Q71398993 | ||
| C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f met-leu-phe antagonists and inhibition by arachidonic acid antagonists | Q71589950 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1095-1102 | |
| P577 | publication date | 1989-06-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes | |
| P478 | volume | 19 |
| Q42267186 | A recombinant hybrid anaphylatoxin with dual C3a/C5a activity |
| Q22010463 | Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity |
| Q34318609 | Animal models of inherited complement deficiency |
| Q72285861 | C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils |
| Q36364952 | C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation |
| Q46849680 | Characterization of C3a anaphylatoxin receptor on guinea-pig macrophages |
| Q53855358 | Characterization of the C5a Receptor on Guinea Pig Platelets |
| Q39377453 | Chronic myelogenous leukemia‐derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a |
| Q41707664 | Complement factors and their receptors |
| Q67905649 | Elevated plasma levels of the immunosuppressive complement fragment Ba in renal failure |
| Q78127364 | Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies |
| Q24317197 | Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells |
| Q41211064 | Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1. |
| Q45020939 | Functional activities of synthetic anaphylatoxic peptides in widely used biological assays |
| Q57550757 | Identification of Casoxin C, An Ileum-contracting Peptide Derived From Bovine κ -casein, as an Agonist for C3a Receptors |
| Q40925447 | Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by "G protein-coupled receptor kinases |
| Q71954979 | Mechanisms of C5a and C3a complement fragment-induced [Ca2+]i signaling in mouse microglia |
| Q33926611 | Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping |
| Q48261622 | Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse. |
| Q24541543 | Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors |
| Q68889380 | Reevaluation of the C3a active site using short synthetic C3a analogues |
| Q24653022 | The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes |
Search more.